Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Miguel‐Angel Perales, Larry D. Anderson, Tania Jain, Saad S. Kenderian, Olalekan O. Oluwole, Gunjan L. Shah, Jakub Svoboda, Mehdi Hamadani
Topics & Concepts
ChemoimmunotherapyChimeric antigen receptorMedicineOncologyClinical trialCD19LymphomaInternal medicineImmunologyAntigenImmunotherapyImmune systemRituximabCAR-T cell therapy researchIntegrated Circuits and Semiconductor Failure AnalysisSilicon Carbide Semiconductor Technologies